Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ERYTECH Pharma S.A. Share Issue/Capital Change 2021

Mar 5, 2021

1295_dva_2021-03-05_b6b60043-b469-4feb-9f6b-9c9d74305a49.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Monthly information related to total number of voting rights and shares composing the share capital – February 28, 2021.

Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France

Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP) Website : www.erytech.com

Date Total of shares composing
the share capital
Total of brut (1) voting
rights
Total of net (2) voting
rights
December 31, 2020 20 057 562 21 592 598 21 590 098
January 31, 2021 20 395 482 21 930 518 21 928 018
February 28, 2021 21 139 668 22 668 705 22 666 205

(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.

(2) Without treasury shares.